Software Alternatives & Startups
Register | Login

https://open-gpt.app/ VS DossiMed.ai

Compare https://open-gpt.app/ VS DossiMed.ai and see what are their differences

https://open-gpt.app/

Create ChatGPT Application in seconds

Rating
0 reviews
Alternatives Is it good?
DossiMed.ai

Multilingual medication-adherence & PHR platform for insurers, telcos & pharma — AI prescription OCR, push/WhatsApp/AI-voice reminders, no-login doctor viewer. GDPR-by-design, EU-hosted, FR/AR/EN/NL. White-label, license, or full IP transfer.

Rating
0 reviews
Pricing
Freemium Free trial $3.9 / Monthly
Alternatives Is it good?
CloudCLI
Shared cloud environments for AI coding agents. Run Claude Code, Cursor CLI, Codex, and Gemini CLI from any device, API, or automation tool. sponsored

Base details

Website, pricing, platforms and company facts side by side.

https://open-gpt.app/
DossiMed.ai
Website open-gpt.app dossimed.ai
Pricing —
Freemium Free trial $3.9 / Monthly Official pricing
Platforms —
Android iOS
Company — Startup from Tunisia · 1 - 9 employees · 2026
Listed in —
Telehealth Healthcare Health And Medical Telemedicine Medical Practice Management AI +3

About https://open-gpt.app/ and DossiMed.ai

In their own words, as submitted to SaaSHub.

https://open-gpt.app/
DossiMed.ai

No description of https://open-gpt.app/ yet.

DossiMed is a production-grade medication-adherence and personal-health-record (PHR) platform, built for European compliance and natively localized for French, Arabic, English, and Dutch markets. It is the only platform that combines AI prescription OCR, Arabic RTL-first design, multichannel...

Read more about DossiMed.ai

Features and specs

What each product offers, as listed by its team.

https://open-gpt.app/ 5 features
DossiMed.ai 9 features
  • Accessible AI Chat Interface
    Provides a user-friendly web-based interface for interacting with GPT-based AI models without needing to set up API access or coding knowledge.
  • No Installation Required
    Being a web application, it can be used directly from a browser without downloading or installing any software.
  • Potentially Free or Low-Cost Access
    Many GPT wrapper sites like this offer free tiers or lower-cost access compared to official API pricing, making AI chat more accessible to casual users.
  • Quick Setup
    Users can typically start chatting almost immediately after visiting the site, with minimal account creation or configuration steps.
  • Cross-Platform Compatibility
    Since it runs in a browser, it can be accessed from various devices including desktops, tablets, and smartphones without platform-specific versions.

Possible disadvantages

  • Uncertain Reliability
    Third-party GPT wrapper websites often depend on underlying API access that can be unstable, rate-limited, or discontinued without notice, affecting consistent availability.
  • Data Privacy Concerns
    Using an unofficial third-party service to process conversations raises questions about how user data and conversation history are stored, used, or shared.
  • Limited Transparency
    It may be unclear which underlying AI model version is being used, how up-to-date it is, or what modifications have been made to the base model's behavior.
  • Potential Hidden Costs or Ads
    Free-to-use AI wrapper sites often monetize through ads, premium upsells, or data collection, which may not be clearly disclosed to users upfront.
  • Lack of Official Support
    Unlike official AI platforms, unofficial wrapper sites may lack dedicated customer support, regular updates, or accountability if issues arise.
  • Prescription OCR
    AI-assisted digitization of paper prescriptions and lab reports
  • Medication adherence
    Multichannel reminders: push, WhatsApp, multilingual voice calls
  • Physician viewer
    Read-only doctor access with QR share and audit logs
  • White-label deployment
    Partner branding, locale, sovereign cloud rollout in 6–10 weeks
  • GDPR-by-design
    Articles 13, 9, 27; EU hosting in Switzerland (eu-central-2)
  • Multilingual localization
    Native French, Arabic, English, and Dutch for MENA and EU markets
  • Personal health record
    Secure PHR for prescriptions, labs, and medical documents
  • Family profiles
    Dependent and cohort profiles for insurers and caregivers.
  • Technology licensing
    Exclusive license or full IP transfer by territory or therapeutic area

Analysis

An editorial look at what each product does well and who it suits.

https://open-gpt.app/
DossiMed.ai

Overall verdict

  • I don't have verified, up-to-date information about open-gpt.app, and I'm unable to browse the internet to check its current status, reputation, or legitimacy. I cannot confidently vouch for or against this specific product/service.

Why this product is good

  • I lack real-time access to verify this website's current content, reputation, or user reviews
  • Domain names and their associated services can change ownership and purpose over time
  • Without verification, I cannot confirm if this is a legitimate service, its features, or its safety
  • There are many similarly-named AI tools of varying quality and trustworthiness, making specific verification important

Recommended for

  • Before using this site, research current user reviews on trusted platforms
  • Check the site's SSL certificate, privacy policy, and terms of service
  • Look for verified information about the company or developers behind it
  • Consider well-established alternatives like ChatGPT (OpenAI), Claude (Anthropic), or Gemini (Google) if you need reliable AI assistance
  • Exercise caution with any site requesting payment or personal information without clear verification of legitimacy

Overall verdict

  • I don't have verified, specific information about DossiMed.ai to make a reliable assessment of its quality, features, or performance. I cannot confirm whether this is a legitimate, well-reviewed medical/health-related AI service or provide details about its actual capabilities.

Why this product is good

  • Insufficient verified data available about this specific platform
  • Cannot confirm the company's track record, user reviews, or clinical validation if it's health-related
  • No access to independent testing or user feedback on this product
  • Unable to verify claims the platform may make about its AI capabilities or accuracy

Recommended for

  • Users should independently research DossiMed.ai through official sources, user reviews, and industry publications
  • Verify any medical or health-related claims with qualified healthcare professionals
  • Check for regulatory compliance if the tool is used in clinical or diagnostic contexts
  • Look for third-party validation studies if precision or medical accuracy is claimed
  • Consult recent user reviews and testimonials from verified sources before adoption

Videos

Walkthroughs and reviews on video.

https://open-gpt.app/ 0 videos + Add
DossiMed.ai 1 video + Add

No https://open-gpt.app/ videos yet. You could help us improve this page by suggesting one.

DossiMed demo

Questions & Answers

As answered by people managing https://open-gpt.app/ and DossiMed.ai.

Who are some of the biggest customers of your product?

DossiMed.ai's answer:

DossiMed is in its market-entry and partnership phase and does not yet publicly disclose named customers. The consumer app is live on Google Play for patients and families, and these are the enterprise segments DossiMed engages for white-label, licensing, and IP-transfer deployments:

  • Health insurers (member medication-adherence and chronic-care programs)
  • Telecom operators (health value-added services for subscribers)
  • Pharmaceutical groups (patient-support and adherence programs)
  • Public-health bodies and NGOs across MENA and Africa

Partnership inquiries: https://dossimed.ai/en/partnerships

Which are the primary technologies used for building your product?

DossiMed.ai's answer:

  • Flutter — offline-first cross-platform mobile app (Android and iOS)
  • Supabase / PostgreSQL — hosted in Switzerland (eu-central-2, Zürich) for GDPR adequacy
  • Azure Document Intelligence + GPT-4o — OCR and structuring of prescriptions, lab results, and imaging reports
  • Serverless edge functions — the AI extraction pipeline, portable across AI providers
  • WhatsApp Business API — medication reminder escalation
  • AI voice-call integration — multilingual (French, Arabic, English) voice reminders
  • Web doctor viewer (viewer.dossimed.ai) — read-only access via QR code or secure link, no app or account required

What makes your product unique?

DossiMed.ai's answer:

DossiMed is the only personal health record that bundles AI prescription OCR, a truly multilingual experience (French, Arabic, English, Dutch — with Arabic RTL-first design), a multichannel medication-adherence escalation stack (push → WhatsApp → AI voice call), and a no-login doctor share link in a single app.

It turns paper prescriptions and lab reports into structured, queryable records, auto-generates a visual dosing calendar with real dosage-form icons (pill, half-pill, syrup, drops, inhaler, patch), and lets a whole family be managed in one secure vault. Doctors open a time-limited, read-only view by QR code or secure link — no account, no install. GDPR-by-design, hosted in Switzerland (Supabase eu-central-2).

Why should a person choose your product over its competitors?

DossiMed.ai's answer:

Most alternatives solve only one slice of the problem. Medication apps like Medisafe and MyTherapy are US/EU-centric, manual, and have no Arabic, no AI OCR, and no document vault. National records (Mon Espace Santé, NHS App) are country-bound, with no AI structuring and no escalation reminders. Booking platforms (Doctolib, DabaDoc, Vezeeta) handle appointments, not a patient-owned record.

DossiMed is the only app that combines AI prescription structuring, Arabic RTL, WhatsApp + AI-voice reminder escalation, and a no-login doctor share link in one place — purpose-built for the people across Africa, MENA, and their diasporas who carry paper prescriptions and rely on WhatsApp. It also runs offline-first on low-cost Android devices. Free core tier; Premium from $2.99/month.

How would you describe the primary audience of your product?

DossiMed.ai's answer:

DossiMed serves two audiences.

Consumers: patients and families managing chronic conditions, elderly relatives, and children's treatments — across Francophone Europe, the Netherlands, Tunisia, the Maghreb, the broader MENA region, and African and diaspora communities. It is built especially for multilingual households that need French, Arabic, English, or Dutch in a single family vault, and for caregivers managing a relative's medication from afar.

Partners (B2B): health insurers, telecom operators, and pharmaceutical groups that want a production-grade, GDPR-by-design chronic-care platform to deploy white-label, license by territory or therapeutic area, or acquire as full IP.

What's the story behind your product?

DossiMed.ai's answer:

DossiMed was built by REC SUARL, an export-oriented Tunisian software company, and founded by Yasmine Boudhina — an INSAT engineer with 13+ years in infrastructure and DevOps, a Microsoft Certified Trainer, and a top-3 alum of Founder Institute Middle East.

The idea came from a problem most Western health-tech overlooks: across Africa, the Arab world, and their diasporas, the majority of prescriptions are still handwritten or printed on paper, there is no national patient record, and families coordinate care over WhatsApp. People lose prescriptions, miss doses, and arrive at appointments with no history.

DossiMed was created to give those patients a record that is always with them — multilingual (French, Arabic, English, Dutch), AI-structured, and shareable with any doctor in seconds. It is production-grade, GDPR-by-design, and hosted in Switzerland.

User comments

Share your experience with using https://open-gpt.app/ and DossiMed.ai. For example, how are they different and which one is better?

Log in or Post with
Loading...